Crossref
Afatinib approval for NSCLC brings EGFR TKI story full circle
The Journal of Community and Supportive Oncology · 2014
DOI: 10.12788/jcso.0002 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Community and Supportive Oncology, 2014. Verfasst von James P Stevenson. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Stevenson, J. P. (2014). Afatinib approval for NSCLC brings EGFR TKI story full circle. The Journal of Community and Supportive Oncology. https://doi.org/10.12788/jcso.0002
Vancouver
Stevenson JP. Afatinib approval for NSCLC brings EGFR TKI story full circle. The Journal of Community and Supportive Oncology. 2014. doi:10.12788/jcso.0002
BibTeX
@article{Stevenson2014,
author = {Stevenson, James P},
title = {Afatinib approval for NSCLC brings EGFR TKI story full circle},
journal = {The Journal of Community and Supportive Oncology},
year = {2014},
doi = {10.12788/jcso.0002}
}
EUVIMED